ArticleCardiovascular drugs and therapy2022

SGLT2 Inhibition by Dapagliflozin Attenuates Diabetic Ketoacidosis in Mice with Type-1 Diabetes.

Huan Chen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.